Fresenius Medical Care AG & Co KGaA at JPMorgan Healthcare Conference Transcript
Great. Good afternoon, everybody. I'm David Adlington, head of the research group for the European medtech and services in London. It's my pleasure to introduce Rice Powell, CEO of Fresenius Medical Care. There is no breakout session afterwards. Thanks.
Thank you, David. Before I get into my prepared remarks, I'd like to introduce to you, she's down here in front, Helen Giza, our new CFO. She's been here 60 days, and she's still standing. That's a good thing. Helen, please.
So you'll notice up on the top left, we're talking about 2018. I'm not living in a time warp, but 2018 is the last full year set of numbers we have at the moment. We haven't done Q4, so we're going to give you some view of '18 as a baseline, and then I'll go through the third quarter earnings and give you some detail
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |